Brainstorm Cell Therapeutics Inc.
BCLI
$0.69
$0.00-0.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.31M | -10.85M | -11.45M | -11.09M | -11.62M |
| Total Depreciation and Amortization | 199.00K | 204.00K | 215.00K | 228.00K | 240.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.70M | 1.45M | 1.08M | 768.00K | 221.00K |
| Change in Net Operating Assets | 1.43M | 1.91M | 676.00K | 2.43M | 2.07M |
| Cash from Operations | -6.98M | -7.28M | -9.48M | -7.66M | -9.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 12.00K | 12.00K | 12.00K | 12.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 12.00K | 12.00K | 12.00K | 12.00K |
| Total Debt Issued | 1.48M | 900.00K | 900.00K | 900.00K | -- |
| Total Debt Repaid | -900.00K | -1.10M | -1.10M | -- | -- |
| Issuance of Common Stock | 4.35M | 5.41M | 5.09M | 6.11M | 7.97M |
| Repurchase of Common Stock | -1.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.95M | 1.95M | 1.95M | 1.50M | -- |
| Cash from Financing | 6.88M | 7.16M | 6.85M | 8.51M | 7.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.00K | -113.00K | -2.62M | 865.00K | -1.11M |